Mitochondria as a key player in systemic lupus erythematosus

Area of Science:

• Immunology
• Mitochondrial Biology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by loss of self-tolerance and chronic inflammation.
• While adaptive immunity alterations are well-studied, emerging evidence highlights mitochondrial dysfunction's role in innate immune activation in SLE.
• Key markers include altered mitochondrial DNA copy number, heteroplasmy, and oxidative stress.

Purpose of the Study:

• To elucidate the role of mitochondrial dysfunction in SLE pathogenesis.
• To explore the link between mitochondrial damage and innate immune system activation in SLE.
• To identify potential therapeutic targets within mitochondrial pathways.

Main Methods:

• Review of current literature on mitochondrial dysfunction and SLE.
• Analysis of molecular pathways involving mitochondrial damage, oxidative stress, and innate immune sensing.
• Examination of cellular processes such as mitophagy, apoptosis, and NETosis in SLE.

Main Results:

• Mitochondrial dysfunction contributes to SLE by releasing oxidized mitochondrial DNA (mtDNA), activating Toll-like receptors and cytosolic DNA sensors.
• Oxidative stress induces post-translational modifications and promotes the release of oxidized mtDNA.
• Reduced mitophagy, altered apoptosis, and NETosis are observed in SLE, leading to persistent mtDNA exposure and immune stimulation.

Conclusions:

• Mitochondrial dysfunction is a significant driver of SLE pathogenesis, particularly through innate immune system activation.
• Aberrant mitochondrial processes lead to the release of immunostimulatory oxidized mtDNA, promoting inflammation and autoreactivity.
• Targeting mitochondrial damage pathways presents a promising therapeutic avenue for managing SLE.